Congzhu L. Li

No. 7 Raoping Road
Shantou, 515041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC).

A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC).

Journal: Journal of ovarian research

Published: August 12, 2025

Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.

Iparomlimab and tuvonralimab in previously treated patients with cervical cancer.

Journal: Cell reports. Medicine

Published: May 29, 2025

Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data.

Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data.

Journal: Scientific reports

Published: March 05, 2025

Promising approach for targeting ROBO1 with CAR NK cells to combat ovarian cancer primary tumor cells and organoids.

Promising approach for targeting ROBO1 with CAR NK cells to combat ovarian cancer primary tumor cells and organoids.

Journal: Future science OA

Published: July 29, 2024

Is COVID-19 Vaccination Beneficial for Tumor Patients: A Cross-Sectional Investigation in China.

Is COVID-19 Vaccination Beneficial for Tumor Patients: A Cross-Sectional Investigation in China.

Journal: Immunity, inflammation and disease

Published: June 17, 2024

SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway.

SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway.

Journal: Gynecologic oncology

Published: March 06, 2024

Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma.

Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma.

Journal: Frontiers in immunology

Published: November 13, 2023

Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma.

Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma.

Journal: Frontiers in immunology

Published: November 13, 2023

Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer.

Identification and validation of a novel necroptosis-related molecular signature to evaluate prognosis and immune features in breast cancer.

Journal: Apoptosis : an international journal on programmed cell death

Published: August 22, 2023

Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.

Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.

Journal: Frontiers in surgery

Published: July 15, 2021

The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation.

The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation.

Journal: Frontiers in cell and developmental biology

Published: July 14, 2020

The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors.

The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors.

Journal: Clinical and translational medicine

Published: May 11, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026